Acadia Pharmaceuticals | ACAD - Interest Income


Acadia Pharmaceuticals reported $7.24M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
ALKERMES USD 11.94M 853K Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Biogen USD 31.6M 700K Sep/2025
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Cara Therapeutics USD 347K 74K Mar/2025
Corcept Therapeutics USD 5.02M 7K Sep/2025
Cytokinetics USD 10.25M 2.75M Sep/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
J&J USD 2.12 0.17 Sep/2025
Moderna USD 73M 8M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Prothena USD 3.35M 443K Sep/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025